Shanghai Shyndec Pharmaceutical Co Ltd (600420) — Capital Reinvestment Ratio
Shanghai Shyndec Pharmaceutical Co Ltd (600420) has a Capital Reinvestment Ratio of 0.14x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥486.04 Million) in capital expenditures (CN¥67.11 Million). See 600420 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Shyndec Pharmaceutical Co Ltd Capital Reinvestment Ratio (2004–2025)
This chart tracks Shanghai Shyndec Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 22 annual periods. Check Shanghai Shyndec Pharmaceutical Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Shanghai Shyndec Pharmaceutical Co Ltd (2004–2025)
Year-by-year Capital Reinvestment Ratio for Shanghai Shyndec Pharmaceutical Co Ltd from 2004 to 2025. For live market cap and broader valuation context, see market value of Shanghai Shyndec Pharmaceutical Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | CN¥1.70 Billion | CN¥263.83 Million | ▲ +59.5% |
| 2024 | 0.10x | CN¥2.26 Billion | CN¥219.77 Million | ▼ -53.1% |
| 2023 | 0.21x | CN¥1.72 Billion | CN¥357.19 Million | ▲ +92.9% |
| 2022 | 0.11x | CN¥2.86 Billion | CN¥307.44 Million | ▼ -65.3% |
| 2021 | 0.31x | CN¥1.68 Billion | CN¥521.44 Million | ▲ +28.1% |
| 2020 | 0.24x | CN¥1.56 Billion | CN¥377.98 Million | ▼ -23.8% |
| 2019 | 0.32x | CN¥1.27 Billion | CN¥403.82 Million | ▲ +32.9% |
| 2018 | 0.24x | CN¥1.67 Billion | CN¥399.40 Million | ▲ +228.8% |
| 2017 | 0.07x | CN¥2.31 Billion | CN¥168.44 Million | ▼ -74.7% |
| 2016 | 0.29x | CN¥838.58 Million | CN¥241.30 Million | ▼ -72.2% |
| 2015 | 1.03x | CN¥226.65 Million | CN¥234.52 Million | ▼ -37.9% |
| 2014 | 1.67x | CN¥258.51 Million | CN¥430.53 Million | ▼ -32.6% |
| 2013 | 2.47x | CN¥207.50 Million | CN¥512.62 Million | ▲ +17.8% |
| 2012 | 2.10x | CN¥193.41 Million | CN¥405.52 Million | ▲ +122.3% |
| 2011 | 0.94x | CN¥136.12 Million | CN¥128.40 Million | ▼ -30.4% |
| 2010 | 1.36x | CN¥115.11 Million | CN¥156.02 Million | ▲ +322.0% |
| 2009 | 0.32x | CN¥97.43 Million | CN¥31.29 Million | ▲ +37.5% |
| 2008 | 0.23x | CN¥58.04 Million | CN¥13.56 Million | ▼ -44.2% |
| 2007 | 0.42x | CN¥82.31 Million | CN¥34.45 Million | ▼ -50.3% |
| 2006 | 0.84x | CN¥73.60 Million | CN¥62.00 Million | ▼ -31.9% |
| 2005 | 1.24x | CN¥57.90 Million | CN¥71.65 Million | ▲ +33.4% |
| 2004 | 0.93x | CN¥17.02 Million | CN¥15.79 Million | — |